ConductScience.org, home

Paper25868965

Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis.

Gill BS and 9 others. Gynecol Oncol, 2015. Cited by 72 papers, by iCite.

Cite this record

ConductScience Library. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis. Papers, record 25868965. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25868965

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis.
PubMed
Journal
Gynecol Oncol
PubMed
Year
2015
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
72
iCite
Relative citation ratio, by iCite
3.1
iCite
Revised in PubMed
2022-03-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gill BSBeant S
2Bernard MEMark E
3Lin JFJeff F
4Balasubramani GKGoundappa K
5Rajagopalan MSMalolan S
6Sukumvanich PPaniti
7Krivak TCThomas C
8Olawaiye ABAlexander B
9Kelley JLJoseph L
10Beriwal SSushil

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Vulvar NeoplasmsMajor topic
Adult
Aged
Aged, 80 and over
Chemoradiotherapy, Adjuvant
Chemotherapy, Adjuvant
Cohort Studies
Female
Humans
Lymphatic Metastasis
Middle Aged
Practice Guidelines as Topic
Radiotherapy, Adjuvant
Retrospective Studies
United States
Young Adult

Source PubMed

Download CSV of topics

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in26013393The ideal adjuvant treatment in node positive vulvar cancer is (fill in your best guess here).https://conductscience.org/library/papers/26013393PubMed
Comment in27511840Progress in Vulvar and Endometrial Cancers: Exploiting Anatomy and Biology and Improving Systemic Therapy.https://conductscience.org/library/papers/27511840PubMed

Download CSV of comments and corrections

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.

PMIDTitleJournalYearIn PapersSource
42773184[Vulvar intraepithelial neoplasia and vulvar cancer].Dermatologie (Heidelb)2026https://conductscience.org/library/papers/42773184PubMed
40862362Clinical outcomes and prognostic factors of adjuvant radiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study.J Radiat Res2025https://conductscience.org/library/papers/40862362PubMed
40805118Advances in Vulvar Cancer: A Radiation Oncology Perspective.Cancers (Basel)2025https://conductscience.org/library/papers/40805118PubMed
40735881Cancer of the vulva: 2025 update: FIGO Cancer Report 2025.Int J Gynaecol Obstet2025https://conductscience.org/library/papers/40735881PubMed
40710383Prognostic Factors and Quality of Life in Vulvar Cancer Patients: 12-Year Results from a Eastern European Center.J Pers Med2025https://conductscience.org/library/papers/40710383PubMed
40687871Prognostic Factors for Vulvar Cancer Undergoing Primary Surgery: Case Series from a Single Tertiary Cancer Center.Indian J Surg Oncol2025https://conductscience.org/library/papers/40687871PubMed
40200950Role of hematological biomarkers in predicting oncological outcomes of definitive chemoradiation in locally advanced vulvar carcinoma.J Biol Methods2025https://conductscience.org/library/papers/40200950PubMed
40114861Role of Radiation Therapy in the Management of Locally Advanced Vulvar Cancer-15 Years of Experience at a Tertiary Care Center in Southern India.Indian J Surg Oncol2025https://conductscience.org/library/papers/40114861PubMed
39748686Postoperative radiotherapy in the management of vulvar cancer.Tunis Med2024https://conductscience.org/library/papers/39748686PubMed
39027152Overall survival associated with surgery, radiotherapy, and chemotherapy in metastatic vulvar cancer: A retrospective cohort study based on the SEER database.Cancer Pathog Ther2024https://conductscience.org/library/papers/39027152PubMed
38774492Adjuvant Radiotherapy for Groin Node Metastases Following Surgery for Vulvar Cancer: A Systematic Review.Oncol Rev2024https://conductscience.org/library/papers/38774492PubMed
37900631Lymph Node Metastasis and Patterns of Recurrence in Vulvar Carcinoma: 10 Years' Single Center Experience.Indian J Surg Oncol2023https://conductscience.org/library/papers/37900631PubMed
37369376European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023.Int J Gynecol Cancer2023https://conductscience.org/library/papers/37369376PubMed
36961728Radiation therapy for vulvar cancer: consensus technical guidelines of the GINECOR working group of the Spanish Society of Radiation Oncology. Part 2: radiotherapy recommendations.Clin Transl Oncol2023https://conductscience.org/library/papers/36961728PubMed
36961727Radiation therapy for vulvar cancer: consensus guidelines of the GINECOR working group of the Spanish Society of Radiation Oncology. Part 1: clinical recommendations.Clin Transl Oncol2023https://conductscience.org/library/papers/36961727PubMed
36653060
Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: GROningen INternational Study on Sentinel nodes in Vulvar cancer III (GROINSS-V III/NRG-GY024).
Int J Gynecol Cancer2023https://conductscience.org/library/papers/36653060PubMed
36088437Observational multicenter Italian study on vulvar cancer adjuvant radiotherapy (OLDLADY 1.2): a cooperation among AIRO Gyn, MITO and MaNGO groups.Radiol Med2022https://conductscience.org/library/papers/36088437PubMed
36077719Management of Early-Stage Vulvar Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/36077719PubMed
35458673Electroporation and Electrochemotherapy in Gynecological and Breast Cancer Treatment.Molecules2022https://conductscience.org/library/papers/35458673PubMed
35454862History and Updates of the GROINSS-V Studies.Cancers (Basel)2022https://conductscience.org/library/papers/35454862PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25868965

GET https://conductscience.org/api/papers/v1/25868965/cited_by?page=2